nodes	percent_of_prediction	percent_of_DWPC	metapath
Pravastatin—SLCO1A2—Chlorambucil—testicular cancer	0.107	0.125	CbGbCtD
Pravastatin—SLC16A1—Methotrexate—testicular cancer	0.0554	0.0651	CbGbCtD
Pravastatin—ABCB11—Vinblastine—testicular cancer	0.0506	0.0594	CbGbCtD
Pravastatin—ABCG2—Dactinomycin—testicular cancer	0.0384	0.0451	CbGbCtD
Pravastatin—ABCB11—Doxorubicin—testicular cancer	0.0311	0.0365	CbGbCtD
Pravastatin—SLCO1B3—Methotrexate—testicular cancer	0.0309	0.0363	CbGbCtD
Pravastatin—SLC22A11—Methotrexate—testicular cancer	0.0286	0.0336	CbGbCtD
Pravastatin—ABCC2—Carboplatin—testicular cancer	0.0285	0.0335	CbGbCtD
Pravastatin—SLC22A7—Methotrexate—testicular cancer	0.0272	0.032	CbGbCtD
Pravastatin—ABCC2—Vinblastine—testicular cancer	0.0266	0.0312	CbGbCtD
Pravastatin—ABCG2—Carboplatin—testicular cancer	0.0258	0.0303	CbGbCtD
Pravastatin—CYP3A5—Ifosfamide—testicular cancer	0.0251	0.0295	CbGbCtD
Pravastatin—ABCC2—Cisplatin—testicular cancer	0.0244	0.0287	CbGbCtD
Pravastatin—CYP2C8—Ifosfamide—testicular cancer	0.0242	0.0284	CbGbCtD
Pravastatin—ABCC2—Etoposide—testicular cancer	0.024	0.0282	CbGbCtD
Pravastatin—ABCG2—Cisplatin—testicular cancer	0.0221	0.0259	CbGbCtD
Pravastatin—ABCG2—Etoposide—testicular cancer	0.0217	0.0255	CbGbCtD
Pravastatin—SLCO1A2—Methotrexate—testicular cancer	0.0191	0.0224	CbGbCtD
Pravastatin—SLCO1B1—Methotrexate—testicular cancer	0.018	0.0212	CbGbCtD
Pravastatin—CYP2C9—Ifosfamide—testicular cancer	0.0168	0.0198	CbGbCtD
Pravastatin—SLC22A8—Methotrexate—testicular cancer	0.0166	0.0195	CbGbCtD
Pravastatin—ABCC2—Doxorubicin—testicular cancer	0.0163	0.0192	CbGbCtD
Pravastatin—ABCC2—Methotrexate—testicular cancer	0.0158	0.0186	CbGbCtD
Pravastatin—ABCG2—Doxorubicin—testicular cancer	0.0148	0.0174	CbGbCtD
Pravastatin—ABCG2—Methotrexate—testicular cancer	0.0143	0.0168	CbGbCtD
Pravastatin—ABCB1—Dactinomycin—testicular cancer	0.0138	0.0163	CbGbCtD
Pravastatin—CYP3A5—Etoposide—testicular cancer	0.012	0.0141	CbGbCtD
Pravastatin—SLC22A6—Methotrexate—testicular cancer	0.0116	0.0136	CbGbCtD
Pravastatin—CYP2C8—Etoposide—testicular cancer	0.0115	0.0136	CbGbCtD
Pravastatin—CYP3A4—Ifosfamide—testicular cancer	0.00979	0.0115	CbGbCtD
Pravastatin—ABCB1—Vinblastine—testicular cancer	0.00867	0.0102	CbGbCtD
Pravastatin—CYP2C9—Cisplatin—testicular cancer	0.00819	0.00962	CbGbCtD
Pravastatin—CYP2D6—Vinblastine—testicular cancer	0.00817	0.0096	CbGbCtD
Pravastatin—ABCB1—Cisplatin—testicular cancer	0.00795	0.00934	CbGbCtD
Pravastatin—ABCB1—Etoposide—testicular cancer	0.00781	0.00918	CbGbCtD
Pravastatin—ABCB1—Doxorubicin—testicular cancer	0.00533	0.00626	CbGbCtD
Pravastatin—CYP3A4—Vinblastine—testicular cancer	0.0052	0.0061	CbGbCtD
Pravastatin—ABCB1—Methotrexate—testicular cancer	0.00516	0.00606	CbGbCtD
Pravastatin—CYP2D6—Doxorubicin—testicular cancer	0.00502	0.0059	CbGbCtD
Pravastatin—CYP3A4—Etoposide—testicular cancer	0.00468	0.0055	CbGbCtD
Pravastatin—CYP3A4—Doxorubicin—testicular cancer	0.00319	0.00375	CbGbCtD
Pravastatin—Decreased appetite—Cisplatin—testicular cancer	0.000172	0.00116	CcSEcCtD
Pravastatin—Diarrhoea—Dactinomycin—testicular cancer	0.000172	0.00116	CcSEcCtD
Pravastatin—Nasopharyngitis—Doxorubicin—testicular cancer	0.000171	0.00116	CcSEcCtD
Pravastatin—Vomiting—Bleomycin—testicular cancer	0.000171	0.00115	CcSEcCtD
Pravastatin—Depression—Methotrexate—testicular cancer	0.00017	0.00115	CcSEcCtD
Pravastatin—Rash—Bleomycin—testicular cancer	0.000169	0.00114	CcSEcCtD
Pravastatin—Pain—Cisplatin—testicular cancer	0.000169	0.00114	CcSEcCtD
Pravastatin—Dermatitis—Bleomycin—testicular cancer	0.000169	0.00114	CcSEcCtD
Pravastatin—Hypersensitivity—Ifosfamide—testicular cancer	0.000169	0.00114	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000169	0.00114	CcSEcCtD
Pravastatin—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000169	0.00114	CcSEcCtD
Pravastatin—Muscular weakness—Doxorubicin—testicular cancer	0.000169	0.00114	CcSEcCtD
Pravastatin—Dysuria—Epirubicin—testicular cancer	0.000167	0.00113	CcSEcCtD
Pravastatin—Abdominal distension—Doxorubicin—testicular cancer	0.000167	0.00112	CcSEcCtD
Pravastatin—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000166	0.00112	CcSEcCtD
Pravastatin—Influenza—Doxorubicin—testicular cancer	0.000165	0.00112	CcSEcCtD
Pravastatin—Asthenia—Ifosfamide—testicular cancer	0.000165	0.00111	CcSEcCtD
Pravastatin—Eosinophilia—Doxorubicin—testicular cancer	0.000164	0.00111	CcSEcCtD
Pravastatin—Photosensitivity reaction—Epirubicin—testicular cancer	0.000163	0.0011	CcSEcCtD
Pravastatin—Feeling abnormal—Cisplatin—testicular cancer	0.000163	0.0011	CcSEcCtD
Pravastatin—Paraesthesia—Etoposide—testicular cancer	0.000163	0.0011	CcSEcCtD
Pravastatin—Weight increased—Epirubicin—testicular cancer	0.000163	0.0011	CcSEcCtD
Pravastatin—Pruritus—Ifosfamide—testicular cancer	0.000163	0.0011	CcSEcCtD
Pravastatin—Pancreatitis—Doxorubicin—testicular cancer	0.000162	0.00109	CcSEcCtD
Pravastatin—Weight decreased—Epirubicin—testicular cancer	0.000162	0.00109	CcSEcCtD
Pravastatin—Dyspnoea—Etoposide—testicular cancer	0.000162	0.00109	CcSEcCtD
Pravastatin—Angina pectoris—Doxorubicin—testicular cancer	0.000161	0.00109	CcSEcCtD
Pravastatin—Nausea—Bleomycin—testicular cancer	0.00016	0.00108	CcSEcCtD
Pravastatin—Vomiting—Dactinomycin—testicular cancer	0.000159	0.00108	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000158	0.00107	CcSEcCtD
Pravastatin—Rash—Dactinomycin—testicular cancer	0.000158	0.00107	CcSEcCtD
Pravastatin—Decreased appetite—Etoposide—testicular cancer	0.000158	0.00106	CcSEcCtD
Pravastatin—Diarrhoea—Ifosfamide—testicular cancer	0.000157	0.00106	CcSEcCtD
Pravastatin—Body temperature increased—Cisplatin—testicular cancer	0.000157	0.00106	CcSEcCtD
Pravastatin—Fatigue—Etoposide—testicular cancer	0.000156	0.00106	CcSEcCtD
Pravastatin—Neuropathy peripheral—Epirubicin—testicular cancer	0.000156	0.00105	CcSEcCtD
Pravastatin—Jaundice—Epirubicin—testicular cancer	0.000155	0.00105	CcSEcCtD
Pravastatin—Pain—Etoposide—testicular cancer	0.000155	0.00105	CcSEcCtD
Pravastatin—Constipation—Etoposide—testicular cancer	0.000155	0.00105	CcSEcCtD
Pravastatin—Urinary tract infection—Epirubicin—testicular cancer	0.000155	0.00105	CcSEcCtD
Pravastatin—Dysuria—Doxorubicin—testicular cancer	0.000155	0.00104	CcSEcCtD
Pravastatin—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000154	0.00104	CcSEcCtD
Pravastatin—Hepatitis—Methotrexate—testicular cancer	0.000153	0.00103	CcSEcCtD
Pravastatin—Dizziness—Ifosfamide—testicular cancer	0.000152	0.00103	CcSEcCtD
Pravastatin—Pharyngitis—Methotrexate—testicular cancer	0.000152	0.00102	CcSEcCtD
Pravastatin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000151	0.00102	CcSEcCtD
Pravastatin—Weight increased—Doxorubicin—testicular cancer	0.000151	0.00102	CcSEcCtD
Pravastatin—Weight decreased—Doxorubicin—testicular cancer	0.00015	0.00101	CcSEcCtD
Pravastatin—Sinusitis—Epirubicin—testicular cancer	0.00015	0.00101	CcSEcCtD
Pravastatin—Feeling abnormal—Etoposide—testicular cancer	0.00015	0.00101	CcSEcCtD
Pravastatin—Nausea—Dactinomycin—testicular cancer	0.000149	0.001	CcSEcCtD
Pravastatin—Gastrointestinal pain—Etoposide—testicular cancer	0.000148	0.001	CcSEcCtD
Pravastatin—Visual impairment—Methotrexate—testicular cancer	0.000147	0.000995	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000146	0.000987	CcSEcCtD
Pravastatin—Vomiting—Ifosfamide—testicular cancer	0.000146	0.000986	CcSEcCtD
Pravastatin—Hypersensitivity—Cisplatin—testicular cancer	0.000146	0.000985	CcSEcCtD
Pravastatin—Rash—Ifosfamide—testicular cancer	0.000145	0.000977	CcSEcCtD
Pravastatin—Dermatitis—Ifosfamide—testicular cancer	0.000145	0.000977	CcSEcCtD
Pravastatin—Erythema multiforme—Methotrexate—testicular cancer	0.000145	0.000976	CcSEcCtD
Pravastatin—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000145	0.000976	CcSEcCtD
Pravastatin—Urticaria—Etoposide—testicular cancer	0.000144	0.000973	CcSEcCtD
Pravastatin—Jaundice—Doxorubicin—testicular cancer	0.000144	0.000971	CcSEcCtD
Pravastatin—Rhinitis—Epirubicin—testicular cancer	0.000144	0.000969	CcSEcCtD
Pravastatin—Abdominal pain—Etoposide—testicular cancer	0.000143	0.000968	CcSEcCtD
Pravastatin—Body temperature increased—Etoposide—testicular cancer	0.000143	0.000968	CcSEcCtD
Pravastatin—Urinary tract infection—Doxorubicin—testicular cancer	0.000143	0.000968	CcSEcCtD
Pravastatin—Hepatitis—Epirubicin—testicular cancer	0.000143	0.000966	CcSEcCtD
Pravastatin—Tinnitus—Methotrexate—testicular cancer	0.000143	0.000963	CcSEcCtD
Pravastatin—Hypoaesthesia—Epirubicin—testicular cancer	0.000142	0.000961	CcSEcCtD
Pravastatin—Asthenia—Cisplatin—testicular cancer	0.000142	0.000959	CcSEcCtD
Pravastatin—Pharyngitis—Epirubicin—testicular cancer	0.000142	0.000959	CcSEcCtD
Pravastatin—Cardiac disorder—Methotrexate—testicular cancer	0.000142	0.000958	CcSEcCtD
Pravastatin—Sinusitis—Doxorubicin—testicular cancer	0.000138	0.000934	CcSEcCtD
Pravastatin—Visual impairment—Epirubicin—testicular cancer	0.000138	0.000931	CcSEcCtD
Pravastatin—Chills—Methotrexate—testicular cancer	0.000137	0.000926	CcSEcCtD
Pravastatin—Nausea—Ifosfamide—testicular cancer	0.000136	0.000921	CcSEcCtD
Pravastatin—Diarrhoea—Cisplatin—testicular cancer	0.000136	0.000914	CcSEcCtD
Pravastatin—Erythema multiforme—Epirubicin—testicular cancer	0.000135	0.000913	CcSEcCtD
Pravastatin—Alopecia—Methotrexate—testicular cancer	0.000135	0.000912	CcSEcCtD
Pravastatin—Hypersensitivity—Etoposide—testicular cancer	0.000134	0.000902	CcSEcCtD
Pravastatin—Tinnitus—Epirubicin—testicular cancer	0.000133	0.000901	CcSEcCtD
Pravastatin—Flushing—Epirubicin—testicular cancer	0.000133	0.000897	CcSEcCtD
Pravastatin—Cardiac disorder—Epirubicin—testicular cancer	0.000133	0.000897	CcSEcCtD
Pravastatin—Rhinitis—Doxorubicin—testicular cancer	0.000133	0.000896	CcSEcCtD
Pravastatin—Hepatitis—Doxorubicin—testicular cancer	0.000132	0.000894	CcSEcCtD
Pravastatin—Hypoaesthesia—Doxorubicin—testicular cancer	0.000132	0.000889	CcSEcCtD
Pravastatin—Pharyngitis—Doxorubicin—testicular cancer	0.000131	0.000887	CcSEcCtD
Pravastatin—Dysgeusia—Methotrexate—testicular cancer	0.00013	0.00088	CcSEcCtD
Pravastatin—Asthenia—Etoposide—testicular cancer	0.00013	0.000879	CcSEcCtD
Pravastatin—Chills—Epirubicin—testicular cancer	0.000128	0.000867	CcSEcCtD
Pravastatin—Pruritus—Etoposide—testicular cancer	0.000128	0.000866	CcSEcCtD
Pravastatin—Arrhythmia—Epirubicin—testicular cancer	0.000128	0.000863	CcSEcCtD
Pravastatin—Visual impairment—Doxorubicin—testicular cancer	0.000128	0.000861	CcSEcCtD
Pravastatin—Alopecia—Epirubicin—testicular cancer	0.000127	0.000854	CcSEcCtD
Pravastatin—Vomiting—Cisplatin—testicular cancer	0.000126	0.00085	CcSEcCtD
Pravastatin—Vision blurred—Methotrexate—testicular cancer	0.000125	0.000847	CcSEcCtD
Pravastatin—Erythema multiforme—Doxorubicin—testicular cancer	0.000125	0.000845	CcSEcCtD
Pravastatin—Rash—Cisplatin—testicular cancer	0.000125	0.000843	CcSEcCtD
Pravastatin—Dermatitis—Cisplatin—testicular cancer	0.000125	0.000842	CcSEcCtD
Pravastatin—Diarrhoea—Etoposide—testicular cancer	0.000124	0.000838	CcSEcCtD
Pravastatin—Ill-defined disorder—Methotrexate—testicular cancer	0.000124	0.000834	CcSEcCtD
Pravastatin—Tinnitus—Doxorubicin—testicular cancer	0.000124	0.000833	CcSEcCtD
Pravastatin—Anaemia—Methotrexate—testicular cancer	0.000123	0.000831	CcSEcCtD
Pravastatin—Flushing—Doxorubicin—testicular cancer	0.000123	0.00083	CcSEcCtD
Pravastatin—Cardiac disorder—Doxorubicin—testicular cancer	0.000123	0.00083	CcSEcCtD
Pravastatin—Flatulence—Epirubicin—testicular cancer	0.000123	0.000829	CcSEcCtD
Pravastatin—Tension—Epirubicin—testicular cancer	0.000122	0.000825	CcSEcCtD
Pravastatin—Dysgeusia—Epirubicin—testicular cancer	0.000122	0.000824	CcSEcCtD
Pravastatin—Nervousness—Epirubicin—testicular cancer	0.000121	0.000817	CcSEcCtD
Pravastatin—Malaise—Methotrexate—testicular cancer	0.00012	0.00081	CcSEcCtD
Pravastatin—Dizziness—Etoposide—testicular cancer	0.00012	0.00081	CcSEcCtD
Pravastatin—Muscle spasms—Epirubicin—testicular cancer	0.00012	0.000809	CcSEcCtD
Pravastatin—Vertigo—Methotrexate—testicular cancer	0.00012	0.000807	CcSEcCtD
Pravastatin—Leukopenia—Methotrexate—testicular cancer	0.000119	0.000804	CcSEcCtD
Pravastatin—Chills—Doxorubicin—testicular cancer	0.000119	0.000802	CcSEcCtD
Pravastatin—Arrhythmia—Doxorubicin—testicular cancer	0.000118	0.000799	CcSEcCtD
Pravastatin—Nausea—Cisplatin—testicular cancer	0.000118	0.000794	CcSEcCtD
Pravastatin—Vision blurred—Epirubicin—testicular cancer	0.000117	0.000793	CcSEcCtD
Pravastatin—Alopecia—Doxorubicin—testicular cancer	0.000117	0.00079	CcSEcCtD
Pravastatin—Cough—Methotrexate—testicular cancer	0.000116	0.000784	CcSEcCtD
Pravastatin—Ill-defined disorder—Epirubicin—testicular cancer	0.000116	0.00078	CcSEcCtD
Pravastatin—Vomiting—Etoposide—testicular cancer	0.000115	0.000779	CcSEcCtD
Pravastatin—Anaemia—Epirubicin—testicular cancer	0.000115	0.000777	CcSEcCtD
Pravastatin—Rash—Etoposide—testicular cancer	0.000114	0.000772	CcSEcCtD
Pravastatin—Dermatitis—Etoposide—testicular cancer	0.000114	0.000771	CcSEcCtD
Pravastatin—Headache—Etoposide—testicular cancer	0.000114	0.000767	CcSEcCtD
Pravastatin—Flatulence—Doxorubicin—testicular cancer	0.000114	0.000767	CcSEcCtD
Pravastatin—Chest pain—Methotrexate—testicular cancer	0.000113	0.000765	CcSEcCtD
Pravastatin—Arthralgia—Methotrexate—testicular cancer	0.000113	0.000765	CcSEcCtD
Pravastatin—Myalgia—Methotrexate—testicular cancer	0.000113	0.000765	CcSEcCtD
Pravastatin—Tension—Doxorubicin—testicular cancer	0.000113	0.000764	CcSEcCtD
Pravastatin—Dysgeusia—Doxorubicin—testicular cancer	0.000113	0.000762	CcSEcCtD
Pravastatin—Malaise—Epirubicin—testicular cancer	0.000112	0.000758	CcSEcCtD
Pravastatin—Discomfort—Methotrexate—testicular cancer	0.000112	0.000756	CcSEcCtD
Pravastatin—Nervousness—Doxorubicin—testicular cancer	0.000112	0.000756	CcSEcCtD
Pravastatin—Vertigo—Epirubicin—testicular cancer	0.000112	0.000756	CcSEcCtD
Pravastatin—Leukopenia—Epirubicin—testicular cancer	0.000112	0.000753	CcSEcCtD
Pravastatin—Muscle spasms—Doxorubicin—testicular cancer	0.000111	0.000748	CcSEcCtD
Pravastatin—Confusional state—Methotrexate—testicular cancer	0.00011	0.00074	CcSEcCtD
Pravastatin—Cough—Epirubicin—testicular cancer	0.000109	0.000734	CcSEcCtD
Pravastatin—Anaphylactic shock—Methotrexate—testicular cancer	0.000109	0.000733	CcSEcCtD
Pravastatin—Vision blurred—Doxorubicin—testicular cancer	0.000109	0.000733	CcSEcCtD
Pravastatin—Infection—Methotrexate—testicular cancer	0.000108	0.000729	CcSEcCtD
Pravastatin—Nausea—Etoposide—testicular cancer	0.000108	0.000727	CcSEcCtD
Pravastatin—Hypertension—Epirubicin—testicular cancer	0.000108	0.000726	CcSEcCtD
Pravastatin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000107	0.000722	CcSEcCtD
Pravastatin—Anaemia—Doxorubicin—testicular cancer	0.000107	0.000719	CcSEcCtD
Pravastatin—Thrombocytopenia—Methotrexate—testicular cancer	0.000106	0.000718	CcSEcCtD
Pravastatin—Myalgia—Epirubicin—testicular cancer	0.000106	0.000716	CcSEcCtD
Pravastatin—Chest pain—Epirubicin—testicular cancer	0.000106	0.000716	CcSEcCtD
Pravastatin—Arthralgia—Epirubicin—testicular cancer	0.000106	0.000716	CcSEcCtD
Pravastatin—Anxiety—Epirubicin—testicular cancer	0.000106	0.000714	CcSEcCtD
Pravastatin—Hyperhidrosis—Methotrexate—testicular cancer	0.000105	0.000709	CcSEcCtD
Pravastatin—Discomfort—Epirubicin—testicular cancer	0.000105	0.000707	CcSEcCtD
Pravastatin—Malaise—Doxorubicin—testicular cancer	0.000104	0.000702	CcSEcCtD
Pravastatin—Vertigo—Doxorubicin—testicular cancer	0.000104	0.000699	CcSEcCtD
Pravastatin—Anorexia—Methotrexate—testicular cancer	0.000104	0.000699	CcSEcCtD
Pravastatin—Leukopenia—Doxorubicin—testicular cancer	0.000103	0.000697	CcSEcCtD
Pravastatin—Confusional state—Epirubicin—testicular cancer	0.000103	0.000692	CcSEcCtD
Pravastatin—Anaphylactic shock—Epirubicin—testicular cancer	0.000102	0.000686	CcSEcCtD
Pravastatin—Oedema—Epirubicin—testicular cancer	0.000102	0.000686	CcSEcCtD
Pravastatin—Infection—Epirubicin—testicular cancer	0.000101	0.000682	CcSEcCtD
Pravastatin—Cough—Doxorubicin—testicular cancer	0.000101	0.000679	CcSEcCtD
Pravastatin—Thrombocytopenia—Epirubicin—testicular cancer	9.96e-05	0.000672	CcSEcCtD
Pravastatin—Hypertension—Doxorubicin—testicular cancer	9.96e-05	0.000672	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Methotrexate—testicular cancer	9.9e-05	0.000668	CcSEcCtD
Pravastatin—Hyperhidrosis—Epirubicin—testicular cancer	9.83e-05	0.000664	CcSEcCtD
Pravastatin—Insomnia—Methotrexate—testicular cancer	9.83e-05	0.000663	CcSEcCtD
Pravastatin—Arthralgia—Doxorubicin—testicular cancer	9.82e-05	0.000662	CcSEcCtD
Pravastatin—Chest pain—Doxorubicin—testicular cancer	9.82e-05	0.000662	CcSEcCtD
Pravastatin—Myalgia—Doxorubicin—testicular cancer	9.82e-05	0.000662	CcSEcCtD
Pravastatin—Anxiety—Doxorubicin—testicular cancer	9.78e-05	0.00066	CcSEcCtD
Pravastatin—Paraesthesia—Methotrexate—testicular cancer	9.76e-05	0.000659	CcSEcCtD
Pravastatin—Discomfort—Doxorubicin—testicular cancer	9.7e-05	0.000655	CcSEcCtD
Pravastatin—Anorexia—Epirubicin—testicular cancer	9.69e-05	0.000654	CcSEcCtD
Pravastatin—Dyspnoea—Methotrexate—testicular cancer	9.69e-05	0.000654	CcSEcCtD
Pravastatin—Dyspepsia—Methotrexate—testicular cancer	9.57e-05	0.000646	CcSEcCtD
Pravastatin—Confusional state—Doxorubicin—testicular cancer	9.49e-05	0.00064	CcSEcCtD
Pravastatin—Decreased appetite—Methotrexate—testicular cancer	9.45e-05	0.000638	CcSEcCtD
Pravastatin—Anaphylactic shock—Doxorubicin—testicular cancer	9.41e-05	0.000635	CcSEcCtD
Pravastatin—Oedema—Doxorubicin—testicular cancer	9.41e-05	0.000635	CcSEcCtD
Pravastatin—Fatigue—Methotrexate—testicular cancer	9.37e-05	0.000632	CcSEcCtD
Pravastatin—Infection—Doxorubicin—testicular cancer	9.35e-05	0.000631	CcSEcCtD
Pravastatin—Pain—Methotrexate—testicular cancer	9.29e-05	0.000627	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Epirubicin—testicular cancer	9.27e-05	0.000625	CcSEcCtD
Pravastatin—Thrombocytopenia—Doxorubicin—testicular cancer	9.21e-05	0.000622	CcSEcCtD
Pravastatin—Insomnia—Epirubicin—testicular cancer	9.2e-05	0.000621	CcSEcCtD
Pravastatin—Paraesthesia—Epirubicin—testicular cancer	9.13e-05	0.000616	CcSEcCtD
Pravastatin—Hyperhidrosis—Doxorubicin—testicular cancer	9.1e-05	0.000614	CcSEcCtD
Pravastatin—Dyspnoea—Epirubicin—testicular cancer	9.07e-05	0.000612	CcSEcCtD
Pravastatin—Anorexia—Doxorubicin—testicular cancer	8.97e-05	0.000605	CcSEcCtD
Pravastatin—Feeling abnormal—Methotrexate—testicular cancer	8.96e-05	0.000604	CcSEcCtD
Pravastatin—Dyspepsia—Epirubicin—testicular cancer	8.95e-05	0.000604	CcSEcCtD
Pravastatin—Gastrointestinal pain—Methotrexate—testicular cancer	8.89e-05	0.0006	CcSEcCtD
Pravastatin—Decreased appetite—Epirubicin—testicular cancer	8.84e-05	0.000597	CcSEcCtD
Pravastatin—Fatigue—Epirubicin—testicular cancer	8.77e-05	0.000592	CcSEcCtD
Pravastatin—Pain—Epirubicin—testicular cancer	8.7e-05	0.000587	CcSEcCtD
Pravastatin—Constipation—Epirubicin—testicular cancer	8.7e-05	0.000587	CcSEcCtD
Pravastatin—Urticaria—Methotrexate—testicular cancer	8.63e-05	0.000583	CcSEcCtD
Pravastatin—Body temperature increased—Methotrexate—testicular cancer	8.59e-05	0.00058	CcSEcCtD
Pravastatin—Abdominal pain—Methotrexate—testicular cancer	8.59e-05	0.00058	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	8.57e-05	0.000579	CcSEcCtD
Pravastatin—Insomnia—Doxorubicin—testicular cancer	8.51e-05	0.000574	CcSEcCtD
Pravastatin—Paraesthesia—Doxorubicin—testicular cancer	8.45e-05	0.00057	CcSEcCtD
Pravastatin—Dyspnoea—Doxorubicin—testicular cancer	8.39e-05	0.000566	CcSEcCtD
Pravastatin—Feeling abnormal—Epirubicin—testicular cancer	8.38e-05	0.000566	CcSEcCtD
Pravastatin—Gastrointestinal pain—Epirubicin—testicular cancer	8.32e-05	0.000561	CcSEcCtD
Pravastatin—Dyspepsia—Doxorubicin—testicular cancer	8.28e-05	0.000559	CcSEcCtD
Pravastatin—Decreased appetite—Doxorubicin—testicular cancer	8.18e-05	0.000552	CcSEcCtD
Pravastatin—Fatigue—Doxorubicin—testicular cancer	8.11e-05	0.000548	CcSEcCtD
Pravastatin—Urticaria—Epirubicin—testicular cancer	8.08e-05	0.000545	CcSEcCtD
Pravastatin—Constipation—Doxorubicin—testicular cancer	8.05e-05	0.000543	CcSEcCtD
Pravastatin—Pain—Doxorubicin—testicular cancer	8.05e-05	0.000543	CcSEcCtD
Pravastatin—Abdominal pain—Epirubicin—testicular cancer	8.04e-05	0.000543	CcSEcCtD
Pravastatin—Body temperature increased—Epirubicin—testicular cancer	8.04e-05	0.000543	CcSEcCtD
Pravastatin—Hypersensitivity—Methotrexate—testicular cancer	8.01e-05	0.00054	CcSEcCtD
Pravastatin—Asthenia—Methotrexate—testicular cancer	7.8e-05	0.000526	CcSEcCtD
Pravastatin—Feeling abnormal—Doxorubicin—testicular cancer	7.75e-05	0.000523	CcSEcCtD
Pravastatin—Gastrointestinal pain—Doxorubicin—testicular cancer	7.7e-05	0.000519	CcSEcCtD
Pravastatin—Pruritus—Methotrexate—testicular cancer	7.69e-05	0.000519	CcSEcCtD
Pravastatin—Hypersensitivity—Epirubicin—testicular cancer	7.49e-05	0.000506	CcSEcCtD
Pravastatin—Urticaria—Doxorubicin—testicular cancer	7.48e-05	0.000505	CcSEcCtD
Pravastatin—Abdominal pain—Doxorubicin—testicular cancer	7.44e-05	0.000502	CcSEcCtD
Pravastatin—Body temperature increased—Doxorubicin—testicular cancer	7.44e-05	0.000502	CcSEcCtD
Pravastatin—Diarrhoea—Methotrexate—testicular cancer	7.44e-05	0.000502	CcSEcCtD
Pravastatin—Asthenia—Epirubicin—testicular cancer	7.3e-05	0.000492	CcSEcCtD
Pravastatin—Pruritus—Epirubicin—testicular cancer	7.2e-05	0.000486	CcSEcCtD
Pravastatin—Dizziness—Methotrexate—testicular cancer	7.19e-05	0.000485	CcSEcCtD
Pravastatin—Diarrhoea—Epirubicin—testicular cancer	6.96e-05	0.00047	CcSEcCtD
Pravastatin—Hypersensitivity—Doxorubicin—testicular cancer	6.93e-05	0.000468	CcSEcCtD
Pravastatin—Vomiting—Methotrexate—testicular cancer	6.91e-05	0.000466	CcSEcCtD
Pravastatin—Rash—Methotrexate—testicular cancer	6.85e-05	0.000462	CcSEcCtD
Pravastatin—Dermatitis—Methotrexate—testicular cancer	6.85e-05	0.000462	CcSEcCtD
Pravastatin—Headache—Methotrexate—testicular cancer	6.81e-05	0.000459	CcSEcCtD
Pravastatin—Asthenia—Doxorubicin—testicular cancer	6.75e-05	0.000456	CcSEcCtD
Pravastatin—Dizziness—Epirubicin—testicular cancer	6.73e-05	0.000454	CcSEcCtD
Pravastatin—Pruritus—Doxorubicin—testicular cancer	6.66e-05	0.000449	CcSEcCtD
Pravastatin—Vomiting—Epirubicin—testicular cancer	6.47e-05	0.000436	CcSEcCtD
Pravastatin—Nausea—Methotrexate—testicular cancer	6.46e-05	0.000436	CcSEcCtD
Pravastatin—Diarrhoea—Doxorubicin—testicular cancer	6.44e-05	0.000435	CcSEcCtD
Pravastatin—Rash—Epirubicin—testicular cancer	6.41e-05	0.000433	CcSEcCtD
Pravastatin—Dermatitis—Epirubicin—testicular cancer	6.41e-05	0.000432	CcSEcCtD
Pravastatin—Headache—Epirubicin—testicular cancer	6.37e-05	0.00043	CcSEcCtD
Pravastatin—Dizziness—Doxorubicin—testicular cancer	6.22e-05	0.00042	CcSEcCtD
Pravastatin—Nausea—Epirubicin—testicular cancer	6.04e-05	0.000408	CcSEcCtD
Pravastatin—Vomiting—Doxorubicin—testicular cancer	5.98e-05	0.000404	CcSEcCtD
Pravastatin—Rash—Doxorubicin—testicular cancer	5.93e-05	0.0004	CcSEcCtD
Pravastatin—Dermatitis—Doxorubicin—testicular cancer	5.93e-05	0.0004	CcSEcCtD
Pravastatin—Headache—Doxorubicin—testicular cancer	5.9e-05	0.000398	CcSEcCtD
Pravastatin—Nausea—Doxorubicin—testicular cancer	5.59e-05	0.000377	CcSEcCtD
Pravastatin—HMGCR—seminal vesicle—testicular cancer	4.49e-05	0.0798	CbGeAlD
Pravastatin—ABCB11—testis—testicular cancer	3.34e-05	0.0594	CbGeAlD
Pravastatin—HMGCR—gonad—testicular cancer	3.25e-05	0.0577	CbGeAlD
Pravastatin—SLC16A1—gonad—testicular cancer	3.2e-05	0.0568	CbGeAlD
Pravastatin—SLC22A7—testis—testicular cancer	3.01e-05	0.0536	CbGeAlD
Pravastatin—HMGCR—female gonad—testicular cancer	2.64e-05	0.0469	CbGeAlD
Pravastatin—SLC16A1—female gonad—testicular cancer	2.6e-05	0.0462	CbGeAlD
Pravastatin—ABCG2—seminal vesicle—testicular cancer	2.38e-05	0.0423	CbGeAlD
Pravastatin—HMGCR—testis—testicular cancer	2.34e-05	0.0416	CbGeAlD
Pravastatin—SLC16A1—testis—testicular cancer	2.3e-05	0.0409	CbGeAlD
Pravastatin—SLCO2B1—female gonad—testicular cancer	2.23e-05	0.0397	CbGeAlD
Pravastatin—SLCO2B1—testis—testicular cancer	1.98e-05	0.0352	CbGeAlD
Pravastatin—SLCO1A2—testis—testicular cancer	1.82e-05	0.0324	CbGeAlD
Pravastatin—ABCC2—testis—testicular cancer	1.7e-05	0.0302	CbGeAlD
Pravastatin—HMGCR—lymph node—testicular cancer	1.7e-05	0.0301	CbGeAlD
Pravastatin—SLC16A1—lymph node—testicular cancer	1.67e-05	0.0297	CbGeAlD
Pravastatin—SLCO2B1—lymph node—testicular cancer	1.44e-05	0.0255	CbGeAlD
Pravastatin—ABCG2—female gonad—testicular cancer	1.4e-05	0.0248	CbGeAlD
Pravastatin—CYP3A5—female gonad—testicular cancer	1.3e-05	0.0231	CbGeAlD
Pravastatin—CYP2C8—testis—testicular cancer	1.27e-05	0.0227	CbGeAlD
Pravastatin—ABCB1—embryo—testicular cancer	1.25e-05	0.0222	CbGeAlD
Pravastatin—ABCG2—testis—testicular cancer	1.24e-05	0.022	CbGeAlD
Pravastatin—ABCC2—lymph node—testicular cancer	1.23e-05	0.0219	CbGeAlD
Pravastatin—ABCB1—seminal vesicle—testicular cancer	1.17e-05	0.0209	CbGeAlD
Pravastatin—CYP2D6—female gonad—testicular cancer	9.58e-06	0.017	CbGeAlD
Pravastatin—ABCG2—lymph node—testicular cancer	8.98e-06	0.016	CbGeAlD
Pravastatin—CYP2D6—testis—testicular cancer	8.49e-06	0.0151	CbGeAlD
Pravastatin—ABCB1—gonad—testicular cancer	8.48e-06	0.0151	CbGeAlD
Pravastatin—ABCB1—female gonad—testicular cancer	6.89e-06	0.0122	CbGeAlD
Pravastatin—ABCB1—testis—testicular cancer	6.11e-06	0.0109	CbGeAlD
Pravastatin—ABCB1—lymph node—testicular cancer	4.43e-06	0.00787	CbGeAlD
